La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Alibaba Health Information Technology Gestion
Gestion contrôle des critères 3/4
Le PDG Alibaba Health Information Technology's est Difan Shen, nommé en Nov2023, a un mandat de moins d'un an. La rémunération annuelle totale est CN¥ 6.81M, composée du salaire de 25.2% et des bonus 74.8%, y compris les actions et options de la société. détient directement 0.009% des actions de la société, d'une valeur de HK$ 4.36M. La durée moyenne de mandat de l'équipe de direction et du conseil d'administration est respectivement 2 ans et 2 ans.
Informations clés
Difan Shen
Directeur général
CN¥6.8m
Rémunération totale
| Pourcentage du salaire du PDG | 25.2% |
| Durée du mandat du directeur général | less than a year |
| Propriété du PDG | 0.009% |
| Durée moyenne d'occupation des postes de direction | 2.1yrs |
| Durée moyenne du mandat des membres du conseil d'administration | 2.1yrs |
Mises à jour récentes de la gestion
Recent updates
Alibaba Health Information Technology (HKG:241) Is Looking To Continue Growing Its Returns On Capital
Jul 03
After Leaping 26% Alibaba Health Information Technology Limited (HKG:241) Shares Are Not Flying Under The Radar
Jun 07Alibaba Health Information Technology's (HKG:241) Solid Earnings Are Supported By Other Strong Factors
Jun 06Risks Still Elevated At These Prices As Alibaba Health Information Technology Limited (HKG:241) Shares Dive 26%
Apr 21Is Now The Time To Look At Buying Alibaba Health Information Technology Limited (HKG:241)?
Apr 16Alibaba Health Information Technology (HKG:241) Might Have The Makings Of A Multi-Bagger
Mar 29Is There An Opportunity With Alibaba Health Information Technology Limited's (HKG:241) 36% Undervaluation?
Mar 12With A 25% Price Drop For Alibaba Health Information Technology Limited (HKG:241) You'll Still Get What You Pay For
Jan 17Is Now An Opportune Moment To Examine Alibaba Health Information Technology Limited (HKG:241)?
Jan 07Returns On Capital Are Showing Encouraging Signs At Alibaba Health Information Technology (HKG:241)
Dec 15Shareholders Should Be Pleased With Alibaba Health Information Technology Limited's (HKG:241) Price
Sep 28Alibaba Health Information Technology Limited's (HKG:241) Intrinsic Value Is Potentially 25% Below Its Share Price
Jul 02Is Alibaba Health Information Technology Limited (HKG:241) Potentially Undervalued?
Jun 11Estimating The Fair Value Of Alibaba Health Information Technology Limited (HKG:241)
Jun 22Is There An Opportunity With Alibaba Health Information Technology Limited's (HKG:241) 49% Undervaluation?
Dec 01Alibaba Health Information Technology (HKG:241) Is Looking To Continue Growing Its Returns On Capital
Oct 15Estimating The Fair Value Of Alibaba Health Information Technology Limited (HKG:241)
Aug 12Alibaba Health Information Technology (HKG:241) Is Doing The Right Things To Multiply Its Share Price
Jun 25These Analysts Just Made A Huge Downgrade To Their Alibaba Health Information Technology Limited (HKG:241) EPS Forecasts
May 30Earnings Report: Alibaba Health Information Technology Limited Missed Revenue Estimates By 6.8%
May 27The Return Trends At Alibaba Health Information Technology (HKG:241) Look Promising
Mar 23Should You Be Adding Alibaba Health Information Technology (HKG:241) To Your Watchlist Today?
Mar 05How Much Are Alibaba Health Information Technology Limited (HKG:241) Insiders Taking Off The Table?
Feb 15Are Alibaba Health Information Technology's (HKG:241) Statutory Earnings A Good Reflection Of Its Earnings Potential?
Jan 31
If You Had Bought Alibaba Health Information Technology (HKG:241) Stock Three Years Ago, You Could Pocket A 457% Gain Today
Dec 31Has Alibaba Health Information Technology Limited's (HKG:241) Impressive Stock Performance Got Anything to Do With Its Fundamentals?
Dec 16Will Alibaba Health Information Technology's (HKG:241) Growth In ROCE Persist?
Dec 01Analyse de la rémunération des PDG
| Date | Rémunération totale | Salaire | Bénéfices de l'entreprise |
|---|---|---|---|
| Mar 31 2024 | CN¥7m | CN¥2m | CN¥883m |
| Dec 31 2023 | n/a | n/a | CN¥851m |
| Sep 30 2023 | n/a | n/a | CN¥817m |
| Jun 30 2023 | n/a | n/a | CN¥675m |
| Mar 31 2023 | CN¥6m | CN¥1m | CN¥536m |
| Dec 31 2022 | n/a | n/a | CN¥332m |
| Sep 30 2022 | n/a | n/a | CN¥128m |
| Jun 30 2022 | n/a | n/a | -CN¥69m |
| Mar 31 2022 | CN¥6m | CN¥1m | -CN¥266m |
| Dec 31 2021 | n/a | n/a | -CN¥216m |
| Sep 30 2021 | n/a | n/a | -CN¥167m |
| Jun 30 2021 | n/a | n/a | CN¥91m |
| Mar 31 2021 | n/a | n/a | CN¥349m |
| Dec 31 2020 | n/a | n/a | CN¥313m |
| Sep 30 2020 | n/a | n/a | CN¥278m |
| Jun 30 2020 | n/a | n/a | CN¥136m |
| Mar 31 2020 | CN¥12m | CN¥2m | -CN¥7m |
| Dec 31 2019 | n/a | n/a | -CN¥3m |
| Sep 30 2019 | n/a | n/a | CN¥1m |
| Jun 30 2019 | n/a | n/a | -CN¥40m |
| Mar 31 2019 | CN¥7m | CN¥33k | -CN¥82m |
Rémunération vs marché: La rémunération totale de Difan ($USD 954.69K ) est dans la moyenne des entreprises de taille similaire sur le marché Hong Kong ($USD 913.61K ).
Rémunération et revenus: La rémunération de Difan a été cohérente avec les performances de l'entreprise au cours de l'année écoulée.
PDG
Difan Shen (46 yo)
less than a year
Titularisation
CN¥6,814,000
Compensation
Mr. Difan Shen serves as Chief Executive Officer of Alibaba Health Information Technology Limited from November 28, 2023 and serves as Executive Director since October 13, 2021. He was Chief Operating Offi...
Équipe de direction
| Nom | Position | Titularisation | Compensation | Propriété |
|---|---|---|---|---|
| Executive Chairman of the Board | 4.5yrs | CN¥19.00m | 0.0086% CN¥ 4.2m | |
| CEO & Executive Director | less than a year | CN¥6.81m | 0.0089% CN¥ 4.3m | |
| CFO & Executive Director | 4.4yrs | CN¥5.34m | 0.0050% CN¥ 2.4m | |
| Legal Counsel & Joint Company Secretary | 1.7yrs | pas de données | pas de données | |
| Chief Marketing Officer | 2.5yrs | pas de données | pas de données | |
| Chief People Officer | 4.6yrs | pas de données | pas de données | |
| Financial Controller | no data | pas de données | pas de données | |
| Chief Legal Advisor & Joint Company Secretary | 1.1yrs | pas de données | pas de données |
2.1yrs
Durée moyenne de l'emploi
46yo
Âge moyen
Gestion expérimentée: L'équipe de direction de 241 est considérée comme expérimentée (ancienneté moyenne 2 ans).
Membres du conseil d'administration
| Nom | Position | Titularisation | Compensation | Propriété |
|---|---|---|---|---|
| Executive Chairman of the Board | 4.5yrs | CN¥19.00m | 0.0086% CN¥ 4.2m | |
| CEO & Executive Director | 2.9yrs | CN¥6.81m | 0.0089% CN¥ 4.3m | |
| CFO & Executive Director | 3.9yrs | CN¥5.34m | 0.0050% CN¥ 2.4m | |
| Independent Non-Executive Director | 1.1yrs | CN¥411.00k | pas de données | |
| Independent Non-Executive Director | 5.3yrs | CN¥348.00k | pas de données | |
| Independent Non-Executive Director | 1.1yrs | CN¥223.00k | pas de données | |
| Non-Executive Director | 1.3yrs | pas de données | pas de données | |
| Non-Executive Director | less than a year | pas de données | pas de données |
2.1yrs
Durée moyenne de l'emploi
48.5yo
Âge moyen
Conseil d'administration expérimenté: Les membres du conseil d'administration de 241 ne sont pas considérés comme expérimentés (ancienneté moyenne 2 ans), ce qui suggère un nouveau conseil d'administration.